跳至主要内容
临床试验/NCT03079986
NCT03079986Unknown不适用

Chyle Leak After Pancreatic Surgery - CLAP

Ludwig-Maximilians - University of Munich1 个研究点 分布在 1 个国家目标入组 86 人开始时间: 2017年5月31日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
86
试验地点
1
主要终点
Postoperative morbidity

研究概览

简要总结

Currently it is unclear whether postoperative chyle leak (CL) after pancreatic surgery requires treatment. Thus, the present study aims to compare dietary treatment of CL with drain removal despite of persistent CL.

详细描述

With an incidence of up to 11%, postoperative chyle leak (CL) is a frequent phenomenon after pancreatic surgery, where extensive lymph node dissections are indispensable. Postoperative CL is frequently treated with either medium-chain triglyceride diet (MCT-diet) or total parenteral nutrition (TPN). Ignoring CL and removing the surgical drains irrespective of CL may also be discussed. While dietary restrictions are known to hinder postoperative convalescence and prolong the length of stay at the hospital, recent retrospective data show that leaving CL untreated is not associated with an increased morbidity rate. More precisely, removing the surgical drains irrespective of CL does not result in an increased incidence of CT-guided drainages. However, prospective data on CL after pancreatic surgery do not exist in the literature. Accordingly, the present trial aims to compare treatment of CL with dietary restrictions to removing the surgical drains irrespective of CL.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Written informed consent
  • Pancreatic surgery of any kind

排除标准

  • Liver cirrhosis > Child-Pugh grade A
  • History of portal vein thrombosis
  • Portal Hypertension
  • Dropout Criteria:
  • Irresectable Tumor (no surgical resection)
  • Biochemical leak or postoperative pancreatic fistula (POPF)5
  • Serous drainage on POD 5
  • Peritoneal carcinomatosis
  • Portal vein thrombosis
  • Postoperative bile leak
  • Drain volume >1000ml on POD5

研究组 & 干预措施

Ignoring CL (group A)

Experimental

Standard care irrespective of CL.

干预措施: Standard care irrespective of CL (Other)

Dietary treatment (group B)

Active Comparator

Dietary treatment with medium-chain triglyceride diet (MCT-diet) until resolution of CL.

干预措施: Dietary treatment (MCT-diet) (Other)

结局指标

主要结局

Postoperative morbidity

时间窗: 30 days postoperatively

Complications ≥ Clavien-Dindo3 grade IIIa

次要结局

  • Length of stay at the hospital(90 days postoperatively)
  • Time until drain removal(30 days postoperatively)
  • Readmission to the hospital(90 days postoperatively)
  • Weight change(The day before surgery until postoperative day 10)
  • Body mass index (BMI) change(The day before surgery until postoperative day 10)
  • International normalized ration (INR) change(The day before surgery until postoperative day 10)
  • Albumin change(The day before surgery until postoperative day 10)
  • Postoperative cortisol level(8 days postoperatively)
  • Freiburg index of patient satisfaction(Postoperative day 10)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jan D'Haese

Associate professor, principal investigator

Ludwig-Maximilians - University of Munich

研究点 (1)

Loading locations...

相似试验